Objective. Many genetically-induced mutations affect aortic structure and function in mice, but little is known about the influence of background strain. This study quantifies the aortic phenotype in angiotensin II (AngII)-induced hypertension across different strains of wildtype mice.Approach and Results. Adult male C57BL/6J and 129SvEv mice were studied before and after induction of hypertension via subcutaneous infusion of AngII (1000 ng/kg/min) for two weeks, which elevated blood pressure similarly (+31% vs. +32%, systolic). The descending thoracic aortas were placed within a custom computer-controlled biomechanical testing device and subjected to a series of isobaric vasocontraction and vasorelaxation tests as well as novel stiffness testing. Immuno-histological studies quantified medial and adventitial composition as well as CD45 + cellular infiltration. Baseline aortic geometry and biomechanical properties were similar across strains, consistent with the existence of general homeostatic mechanical targets.Nevertheless, aortic remodeling due to AngII-induced hypertension differed dramatically between strains, with gross over-adaptive remodeling (exuberant thickening of the media and adventitia) in C57BL/6J but under-adaptive remodeling in 129SvEv mice. Importantly, vasoconstrictive strength was lower in C57BL/6J than 129SvEv mice, both before and after hypertension, while CD45 + cell content was markedly higher in C57BL/6J than 129SvEv mice following hypertension.
Conclusions.Genetic modifiers likely play a key role in the different hypertensive aortic remodeling between C57BL/6J and 129SvEv mice as well as mixed C57BL/6;129SvEv mice. The lower fibrotic response in 129SvEv mice results from their lower inflammatory state but also greater aortic vasoresponsiveness to AngII, which lowers the wall-stress mechano-stimulus for remodeling. Remodeling in mixed background mice is dominated by the 129SvEv strain. φ m smooth muscle cross-sectional area fraction φ g ground substance/glycosaminoglycan cross-sectional area fraction We are grateful for our prior collaborations with Drs. Jacopo Ferruzzi, Hiromi Yanagisawa, Chiara Bellini, and Dianna M. Milewicz that yielded data for C57BL/6;129SvEv (i.e., Fbln5 +/+ and Myh11 +/+ ) mice (Ferruzzi et al, 2015; Bellini et al., 2015) and, so too, with Dr. David G. Harrison for data for low-rate (490 ng/kg/min) AngII infusion of C57BL/6 mice (Bersi et al., 2016), whichwere used herein as consistent quantitative comparators. We further acknowledge the Yale Pathology Tissue Services for histology and immunohistochemistry.